Feedback
FDBK · AIM · Health Care · mcap £2.8m · 6.3p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 14 Jul 26 | Trading update | Trading Update
Revenue flat at £0.8m; EBITDA loss lower than expected; cash position £2.7m with runway to mid-2027; Bleepa pursuing national NHS contract. |
−4.4% |
| 22 Apr 26 | Director dealing | Grant of Options and PDMR dealing | |
| 20 Apr 26 | NHS Progress and Business Update
NHS central contract decision delayed 6-9 months; QVH licence extended to December 2026; photocapture contract not renewed. |
−25.3% | |
| 17 Feb 26 | Results | Half-year Results
H1 2026 revenue stable at £0.41m; EBITDA loss increased to £1.61m; cash £3.82m with runway to mid-2027. |
+1.4% |
| 17 Feb 26 | Results | Half-year Results
H1 revenue down 8% to £0.41m; EBITDA loss widened to £1.61m; awaiting NHS spending review outcome |
+1.4% |
| 16 Feb 26 | Board change | Confirmation of CFO Board Appointment
CFO Emma Oswick appointed to board of directors, effective immediately. |
−1.4% |
| 02 Feb 26 | Routine | Notice of Results & Retail Investor Presentation | |
| 05 Jan 26 | Holding | Holding(s) in Company | |
| 23 Dec 25 | Holding | Holding(s) in Company | |
| 23 Dec 25 | Director dealing | Director/PDMR Shareholding | |
| 18 Dec 25 | Trading update | Trading Update
Revenue flat at £0.4m for H1 to November 2025; management expects sales momentum to build next tax year. |
+0.0% |
| 20 Oct 25 | Board change | Directorate Change
CFO Anesh Patel to step down on 10 November 2025; Emma Oswick (Stuart) appointed as successor. |
−1.0% |
| 13 Oct 25 | Routine | Result of AGM |
Company filings. Not investment advice.